Ask AI

Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment and Elevate Patient Outcomes

Enhance your understanding of new bispecific antibody therapies used to manage multiple myeloma to personalize treatment and improve patient outcomes through an expert-authored ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Activities

EHA BsAb MM
Advances in Bispecific Antibody Therapy for Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2026

Activities

Advances in BsAbs for MM
Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment and Elevate Patient Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2026

Expires: January 06, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc